These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 12444892

  • 1. Idiopathic precocious puberty versus puberty in adopted children; auxological response to gonadotrophin-releasing hormone agonist treatment and final height.
    Kempers MJ, Otten BJ.
    Eur J Endocrinol; 2002 Nov; 147(5):609-16. PubMed ID: 12444892
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty.
    Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F.
    Eur J Endocrinol; 1999 Aug; 141(2):140-4. PubMed ID: 10427157
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after treatment].
    Messaaoui A, Massa G, Tenoutasse S, Heinrichs C.
    Rev Med Brux; 2005 Feb; 26(1):27-32. PubMed ID: 15816337
    [Abstract] [Full Text] [Related]

  • 4. Treatment of central precocious puberty: lessons from a 15 years prospective trial. German Decapeptyl Study Group.
    Partsch CJ, Heger S, Sippell WG.
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():747-58. PubMed ID: 10969917
    [Abstract] [Full Text] [Related]

  • 5. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R, Soros A, Jakubowicz S.
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [Abstract] [Full Text] [Related]

  • 6. Gonadotrophin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty.
    Mul D, Oostdijk W, Waelkens JJ, Schulpen TW, Drop SL.
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):121-9. PubMed ID: 11453961
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group.
    Oostdijk W, Drop SL, Odink RJ, Hümmelink R, Partsch CJ, Sippell WG.
    Acta Paediatr Scand Suppl; 1991 Jul; 372():39-45; discussion 46. PubMed ID: 1833950
    [Abstract] [Full Text] [Related]

  • 9. Near final height after GnRH agonist treatment in central precocious puberty.
    Micillo M, Salerno M, Officioso A, Perna E, Gasparini N, Pisaturo L, Di Maio S.
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():787-90. PubMed ID: 10969922
    [Abstract] [Full Text] [Related]

  • 10. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
    Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM.
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
    [Abstract] [Full Text] [Related]

  • 11. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I, Segni M, Ortore M, Moretti A, Iannaccone R, Pasquino AM.
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
    [Abstract] [Full Text] [Related]

  • 12. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ, Hümmelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Horm Res; 1993 Jul; 39(3-4):111-7. PubMed ID: 8262471
    [Abstract] [Full Text] [Related]

  • 13. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [Abstract] [Full Text] [Related]

  • 14. Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty.
    Yoo E, Kim S, Jung HL, Shim JY, Shim JW, Kim DS, Kwak JH, Kim ES, Yang A.
    Front Endocrinol (Lausanne); 2023 Jan; 14():1134977. PubMed ID: 36875449
    [Abstract] [Full Text] [Related]

  • 15. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.
    Liang Y, Wei H, Li J, Hou L, Zhang J, Wu W, Ying Y, Luo X.
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):839-46. PubMed ID: 25719299
    [Abstract] [Full Text] [Related]

  • 16. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
    Kapteijns-van Kordelaar S, Noordam K, Otten B, van den Bergh J.
    Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
    [Abstract] [Full Text] [Related]

  • 17. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty.
    Brauner R, Malandry F, Rappaport R.
    Eur J Pediatr; 1992 Oct; 151(10):728-30. PubMed ID: 1425790
    [Abstract] [Full Text] [Related]

  • 18. Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results.
    Mul D, Bertelloni S, Carel JC, Saggese G, Chaussain JL, Oostdijk W.
    Horm Res; 2002 Oct; 58(1):1-7. PubMed ID: 12169774
    [Abstract] [Full Text] [Related]

  • 19. The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty.
    Tung YC, Lee JS, Tsai WY, Hsiao PH.
    J Formos Med Assoc; 2007 Oct; 106(10):826-31. PubMed ID: 17964961
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.